Peripheral muscle dysfunction in chronic obstructive pulmonary disease.

[1]  R. Casaburi.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.

[2]  T. Kufel,et al.  Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[3]  L. Lands,et al.  Effect of supplementation with a cysteine donor on muscular performance. , 1999, Journal of applied physiology.

[4]  M. McKenna,et al.  Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. , 1999, American journal of respiratory and critical care medicine.

[5]  J. Barberà,et al.  Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[6]  F. Maltais,et al.  Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. , 1999, The European respiratory journal.

[7]  D. Poole,et al.  Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[8]  F. Maltais,et al.  Aerobic and strength training in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[9]  F. Maltais,et al.  Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.

[10]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[11]  D. Poole,et al.  Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity , 1998 .

[12]  D. Brooks,et al.  The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. , 1998, Chest.

[13]  F. Maltais,et al.  Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. , 1998, Journal of applied physiology.

[14]  I. Harting,et al.  Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[15]  P. Haslett.  Anticytokine approaches to the treatment of anorexia and cachexia. , 1998, Seminars in oncology.

[16]  A. Varray,et al.  Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. , 1998, Chest.

[17]  S. Schiaffino,et al.  Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. , 1998, The American journal of physiology.

[18]  Rachel Booker Rgn,et al.  Chronic obstructive pulmonary disease , 1998 .

[19]  Moldawer Ll,et al.  Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation. , 1998 .

[20]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[21]  H. Magnussen,et al.  Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. , 1998, The European respiratory journal.

[22]  E. Wouters,et al.  Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[23]  L. Kaiser,et al.  Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. , 1997, The New England journal of medicine.

[24]  C. Reggiani,et al.  Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. , 1997, The European respiratory journal.

[25]  C. Pichard,et al.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.

[26]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[27]  M. Donahoe.  Nutritional support in advanced lung disease. The pulmonary cachexia syndrome. , 1997, Clinics in chest medicine.

[28]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[29]  A. Varray,et al.  Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease. , 1997, Journal of cardiopulmonary rehabilitation.

[30]  J. Payen,et al.  [Skeletal muscle abnormalities in chronic obstructive lung disease with respiratory insufficiency. Value of P31 magnetic resonance spectroscopy]. , 1997, Revue des maladies respiratoires.

[31]  R. Casaburi,et al.  Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[32]  M. Decramer,et al.  Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.

[33]  F. Maltais,et al.  Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[34]  J. Wain,et al.  Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS. , 1997, American journal of respiratory and critical care medicine.

[35]  K. Kalantar-Zadeh,et al.  Nutritional management of renal disease , 1997 .

[36]  F. Maltais,et al.  Lactate Kinetics during Exercise in Chronic Obstructive Pulmonary Disease , 1997 .

[37]  K. Westerterp,et al.  Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[38]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[39]  C. J. Clark,et al.  Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. , 1996, The European respiratory journal.

[40]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[41]  F. Maltais,et al.  Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[42]  N. Ancy,et al.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. , 1996 .

[43]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[44]  G. Heigenhauser,et al.  Getting rid of carbon dioxide during exercise. , 1996, Clinical science.

[45]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[46]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[47]  F. Maltais,et al.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. , 1996, American journal of respiratory and critical care medicine.

[48]  C. Belleguic,et al.  [Pulmonary metastases with a prolonged development. Two cases of thyroid cancers]. , 1996, Revue des maladies respiratoires.

[49]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[50]  D. O’Donnell,et al.  The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. , 1995, American journal of respiratory and critical care medicine.

[51]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[52]  L. Lands,et al.  Skeletal muscle pyruvate dehydrogenase activity during maximal exercise in humans. , 1995, The American journal of physiology.

[53]  L. Jorfeldt,et al.  Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia. , 1995, Respiratory medicine.

[54]  M. Boska,et al.  Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. , 1995, Journal of applied physiology.

[55]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[56]  Mangalam Sridhar.  Why do patients with emphysema lose weight? , 1995, The Lancet.

[57]  J. Gea,et al.  Structure of the latissimus dorsi muscle and respiratory function. , 1995, Journal of applied physiology.

[58]  L. Jorfeldt,et al.  Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. , 1995, American journal of respiratory and critical care medicine.

[59]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[60]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[61]  E. Wouters,et al.  Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. , 1994, The European respiratory journal.

[62]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[63]  M. Decramer,et al.  Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. , 1993, The Journal of clinical investigation.

[64]  L. Moldawer,et al.  Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6. , 1993, Lymphokine and cytokine research.

[65]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[66]  J. Le Bas,et al.  Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. , 1993, The American review of respiratory disease.

[67]  R. Casaburi,et al.  Principles and Practice of Pulmonary Rehabilitation , 1993 .

[68]  W. Evans,et al.  Changes in Skeletal Muscle with Aging: Effects of Exercise Training , 1993, Exercise and sport sciences reviews.

[69]  J. Costantino,et al.  Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. , 1992, The American review of respiratory disease.

[70]  M. Haida,et al.  31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. , 1992, The American review of respiratory disease.

[71]  N. Jones,et al.  Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. , 1992, The American review of respiratory disease.

[72]  E. Fletcher,et al.  Survival in COPD Patients with a Daytime PaO2 >60 mm Hg with and without Nocturnal Oxyhemoglobin Desaturation , 1992 .

[73]  T. Ishizaki,et al.  31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. , 1992, The European respiratory journal.

[74]  A. Benabid,et al.  Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. , 1992, The European respiratory journal.

[75]  N. Jones,et al.  Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. , 1992, Thorax.

[76]  G. Patterson,et al.  Maximal exercise testing in single and double lung transplant recipients. , 1992, The American review of respiratory disease.

[77]  R. Casaburi,et al.  Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. , 1991, The American review of respiratory disease.

[78]  E. Wouters,et al.  Body composition and exercise performance in patients with chronic obstructive pulmonary disease. , 1991, Thorax.

[79]  F. Cobb,et al.  Altered Skeletal Muscle Metabolic Response to Exercise in Chronic Heart Failure: Relation to Skeletal Muscle Aerobic Enzyme Activity , 1991, Circulation.

[80]  D. Allen,et al.  Cellular mechanisms of fatigue in skeletal muscle. , 1991, The American journal of physiology.

[81]  E. Wouters,et al.  Energy balance in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[82]  P. Cerretelli,et al.  Muscle structure and performance capacity of Himalayan Sherpas. , 1991, Journal of applied physiology.

[83]  K. Hellström,et al.  Does chronic hypoxaemia induce transformations of fibre types? , 1991, Acta physiologica Scandinavica.

[84]  D. Norman,et al.  Plasma tumour necrosis factor alpha in cystic fibrosis. , 1991, Thorax.

[85]  P. Buckley,et al.  The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. , 1990, The American review of respiratory disease.

[86]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[87]  E. Fiaccadori,et al.  Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms, and relationships with skeletal muscle phosphorus content. , 1990, Chest.

[88]  L. Jorfeldt,et al.  Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. , 1990, The European respiratory journal.

[89]  W. Frontera,et al.  Strength training and determinants of VO2max in older men. , 1990, Journal of applied physiology.

[90]  E. Fletcher,et al.  Exercise hemodynamics and gas exchange in patients with chronic obstruction pulmonary disease, sleep desaturation, and a daytime PaO2 above 60 mm Hg. , 1989, The American review of respiratory disease.

[91]  S C Gandevia,et al.  Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation. , 1989, Thorax.

[92]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[93]  C S Houston,et al.  Operation Everest II: adaptations in human skeletal muscle. , 1989, Journal of applied physiology.

[94]  A. Harver,et al.  Prediction of peak oxygen consumption in obstructive airway disease. , 1988, Medicine and science in sports and exercise.

[95]  C. Scrimgeour,et al.  Muscle wasting in emphysema. , 1988, Clinical science.

[96]  M. Fairbarn,et al.  Dietary supplementation and respiratory muscle performance in patients with COPD. , 1988, Chest.

[97]  S. Spiro,et al.  The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. , 1988, The American review of respiratory disease.

[98]  J. Kinney,et al.  Nitrogen and energy relationships in malnourished patients with emphysema. , 1988, The American review of respiratory disease.

[99]  Nicoletta,et al.  Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. , 1987, Chest.

[100]  Belman Mj.  Exercise in chronic obstructive pulmonary disease. , 1986, Clinics in chest medicine.

[101]  R. Rogers,et al.  Nutritional intervention in malnourished patients with emphysema. , 1986, The American review of respiratory disease.

[102]  B. Whipp,et al.  Bicarbonate buffering of lactic acid generated during exercise. , 1986, Journal of applied physiology.

[103]  H. Sjöholm,et al.  Effect of induced metabolic acidosis on intracellular pH, buffer capacity and contraction force of human skeletal muscle. , 1985, Clinical science.

[104]  L. Larsson,et al.  Effects of long‐term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man , 1985, Muscle & nerve.

[105]  E. Coyle,et al.  Effects of detraining on responses to submaximal exercise. , 1985, Journal of applied physiology.

[106]  M. Aubier,et al.  Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. , 1985, The New England journal of medicine.

[107]  G. W. Mainwood,et al.  The effect of acid-base balance on fatigue of skeletal muscle. , 1985, Canadian journal of physiology and pharmacology.

[108]  B. Saltin,et al.  Skeletal Muscle Adaptability: Significance for Metabolism and Performance , 1985 .

[109]  E. Coyle,et al.  Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[110]  B. Steyer.  Exercise training in chronic obstructive lung disease. , 1984, Arizona medicine.

[111]  Z. Mohsenifar,et al.  Sensitive indices of improvement in a pulmonary rehabilitation program. , 1983, Chest.

[112]  V. Sahgal,et al.  Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. , 1983, Respiration; international review of thoracic diseases.

[113]  P D Gollnick,et al.  Effects of disuse on the structure and function of skeletal muscle. , 1983, Medicine and science in sports and exercise.

[114]  M. J. Saunders,et al.  Randomised controlled trial of rehabilitation in chronic respiratory disability. , 1981, Thorax.

[115]  R T Withers,et al.  Muscle respiratory capacity and fiber type as determinants of the lactate threshold. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[116]  D. Sinclair,et al.  Controlled trial of supervised exercise training in chronic bronchitis. , 1980, British medical journal.

[117]  G. Hedenstierna,et al.  Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. , 1977, Clinical science and molecular medicine.

[118]  R. Edwards,et al.  Exercise Tolerance in Chronic Airway Obstruction1, 2 , 1971 .

[119]  E. Banister,et al.  Response to exercise in patients with chronic airway obstruction. I. Effects of exercise training. , 1971, The American review of respiratory disease.

[120]  P. Vignos,et al.  Experimental corticosteroid myopathy. , 1969, Arthritis and rheumatism.

[121]  R. Johnson,et al.  An evaluation of exercise tests in chronic obstructive lung disease. , 1969, Journal of applied physiology.

[122]  R. Sutherland.  The Television Debate , 1965 .